10x Genomics, Inc.
TXG
$9.42
$0.313.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -157.04M | -182.63M | -182.55M | -239.78M | -264.30M |
| Total Depreciation and Amortization | 42.03M | 43.71M | 44.85M | 45.52M | 46.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 135.92M | 144.33M | 157.18M | 163.62M | 174.00M |
| Change in Net Operating Assets | 35.83M | 1.25M | 19.70M | 22.87M | 17.01M |
| Cash from Operations | 56.74M | 6.66M | 39.17M | -7.78M | -26.80M |
| Capital Expenditure | -11.38M | -12.39M | -13.13M | -24.47M | -46.95M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.78M | -20.24M | 45.19M | 65.05M | 71.12M |
| Cash from Investing | -45.16M | -32.63M | 32.06M | 40.58M | 24.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 9.70M | 10.91M | 12.01M | 16.23M | 18.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.70M | 10.91M | 12.01M | 16.23M | 18.72M |
| Foreign Exchange rate Adjustments | -2.00K | -164.00K | 182.00K | -59.00K | -105.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.28M | -15.22M | 83.42M | 48.97M | 15.99M |